Aldosterone and cardiovascular disease: The heart of the matter

B. Julie He, Mark E. Anderson

Research output: Contribution to journalReview articlepeer-review

Abstract

Aldosterone contributes to the endocrine basis of heart failure, and studies on cardiac aldosterone signaling have reinforced its value as a therapeutic target. Recent focus has shifted to new roles of aldosterone that appear to depend on coexisting pathologic stimuli, cell type, and disease etiology. This review evaluates recent advances in mechanisms underlying aldosterone-induced cardiac disease and highlights the interplay between aldosterone and Ca2+/calmodulin dependent protein kinase II, whose hyperactivity during heart failure contributes to disease progression. Increasing evidence implicates aldosterone in diastolic dysfunction, and there is a need to develop more targeted therapeutics such as aldosterone synthase inhibitors and molecularly specific antioxidants. Despite accumulating knowledge, many questions still persist and will likely dictate areas of future research.

Original languageEnglish (US)
Pages (from-to)21-30
Number of pages10
JournalTrends in Endocrinology and Metabolism
Volume24
Issue number1
DOIs
StatePublished - Jan 1 2013
Externally publishedYes

Keywords

  • Aldosterone
  • CaMKII
  • Heart failure
  • Signaling

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Fingerprint Dive into the research topics of 'Aldosterone and cardiovascular disease: The heart of the matter'. Together they form a unique fingerprint.

Cite this